Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients

被引:19
|
作者
Clarke, Christina L. [1 ]
Kushi, Lawrence H. [2 ]
Chubak, Jessica [3 ]
Pawloski, Pamala A. [4 ]
Bulkley, Joanna E. [5 ]
Epstein, Mara M. [6 ,7 ]
Burnett-Hartman, Andrea N. [1 ]
Powell, Bethan [8 ]
Pearce, Celeste L. [9 ]
Feigelson, Heather Spencer [1 ]
机构
[1] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA
[2] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[3] Kaiser Permanente Washington, Hlth Res Inst, Seattle, WA USA
[4] HealthPartners Inst, Bloomington, MN USA
[5] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA
[6] Meyers Primary Care Inst, Worcester, MA USA
[7] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA
[8] Kaiser Permanente Northern Calif, Gynecol Oncol Program, San Francisco, CA USA
[9] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
关键词
D O I
10.1158/1055-9965.EPI-18-1324
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Relatively little is known about factors associated with long-term survival (LTS) following a diagnosis of ovarian cancer. Methods: We conducted a retrospective study of high-grade serous ovarian cancer (HGSOC) to explore predictors of LTS (defined as >= 7 years of survival) using electronic medical record data from a network of integrated health care systems. Multivariable logistic regression with forward selection was used to compare characteristics of women who survived >= 7 years after diagnosis (n = 148) to those who died within 7 years of diagnosis (n = 494). Results: Our final model included study site, age, stage at diagnosis, CA-125, comorbidity score, receipt of chemotherapy, BMI, and four separate comorbid conditions: weight loss, depression, hypothyroidism, and liver disease. Of these, only younger age, lower stage, and depression were statistically significantly associated with LTS. Conclusions: We did not identify any new characteristics associated with HGSOC survival. Impact: Prognosis of ovarian cancer generally remains poor. Large, pooled studies of ovarian cancer are needed to identify characteristics that may improve survival.
引用
收藏
页码:996 / 999
页数:4
相关论文
共 50 条
  • [1] What influences the long-term survival of advanced high-grade serous ovarian cancer?
    Xie, X.
    Jin, L.
    Tang, S.
    Shen, Y.
    Cheng, X.
    Lv, W.
    Wan, X.
    Chen, Z.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 347 - 347
  • [2] Protein anabolism is key to long-term survival in high-grade serous ovarian cancer
    Wang, Lingxiang
    Sun, Tao
    Li, Shumei
    Zhang, Zhengmao
    Jia, Jingde
    Shan, Baoen
    TRANSLATIONAL ONCOLOGY, 2021, 14 (01):
  • [3] The genomic landscape of high-grade serous ovarian cancer in long-term survivors
    Garsed, Dale W.
    Pandey, Ahwan
    Fereday, Sian
    Alsop, Kathryn
    Wouters, Maartje C.
    Saner, Flurina
    Beach, Jessica A.
    Milne, Katy
    Kennedy, Catherine J.
    Hendley, Joy
    Traficante, Nadia
    Pearce, Celeste L.
    Pike, Malcolm C.
    Ramus, Susan J.
    Kobel, Martin
    Nelson, Brad H.
    Goode, Ellen L.
    deFazio, Anna
    Bowtell, David D.
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Conditional Probability of Survival and Prognostic Factors in Long-Term Survivors of High-Grade Serous Ovarian Cancer
    Fabbro, Michel
    Colombo, Pierre-Emmanuel
    Leaha, Cristina Marinella
    Rouanet, Philippe
    Carrere, Sebastien
    Quenet, Francois
    Gutowski, Marian
    Mourregot, Anne
    D'Hondt, Veronique
    Coupier, Isabelle
    Vendrell, Julie
    Vilquin, Paul
    Pujol, Pascal
    Solassol, Jerome
    Mollevi, Caroline
    CANCERS, 2020, 12 (08) : 1 - 14
  • [5] The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
    Garsed, Dale W.
    Pandey, Ahwan
    Fereday, Sian
    Kennedy, Catherine J.
    Takahashi, Kazuaki
    Alsop, Kathryn
    Hamilton, Phineas T.
    Hendley, Joy
    Chiew, Yoke-Eng
    Traficante, Nadia
    Provan, Pamela
    Ariyaratne, Dinuka
    Au-Yeung, George
    Bateman, Nicholas W.
    Bowes, Leanne
    Brand, Alison
    Christie, Elizabeth L.
    Cunningham, Julie M.
    Friedlander, Michael
    Grout, Bronwyn
    Harnett, Paul
    Hung, Jillian
    McCauley, Bryan
    McNally, Orla
    Piskorz, Anna M.
    Saner, Flurina A. M.
    Vierkant, Robert A.
    Wang, Chen
    Winham, Stacey J.
    Pharoah, Paul D. P.
    Brenton, James D.
    Conrads, Thomas P.
    Maxwell, George L.
    Ramus, Susan J.
    Pearce, Celeste Leigh
    Pike, Malcolm C.
    Nelson, Brad H.
    Goode, Ellen L.
    DeFazio, Anna
    Bowtell, David D. L.
    NATURE GENETICS, 2022, 54 (12) : 1853 - 1864
  • [6] The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
    Dale W. Garsed
    Ahwan Pandey
    Sian Fereday
    Catherine J. Kennedy
    Kazuaki Takahashi
    Kathryn Alsop
    Phineas T. Hamilton
    Joy Hendley
    Yoke-Eng Chiew
    Nadia Traficante
    Pamela Provan
    Dinuka Ariyaratne
    George Au-Yeung
    Nicholas W. Bateman
    Leanne Bowes
    Alison Brand
    Elizabeth L. Christie
    Julie M. Cunningham
    Michael Friedlander
    Bronwyn Grout
    Paul Harnett
    Jillian Hung
    Bryan McCauley
    Orla McNally
    Anna M. Piskorz
    Flurina A. M. Saner
    Robert A. Vierkant
    Chen Wang
    Stacey J. Winham
    Paul D. P. Pharoah
    James D. Brenton
    Thomas P. Conrads
    George L. Maxwell
    Susan J. Ramus
    Celeste Leigh Pearce
    Malcolm C. Pike
    Brad H. Nelson
    Ellen L. Goode
    Anna DeFazio
    David D. L. Bowtell
    Nature Genetics, 2022, 54 : 1853 - 1864
  • [7] DESCRIBING THE ODDS OF LONG-TERM SURVIVAL AMONG WOMEN DIAGNOSED WITH HIGH-GRADE SEROUS OVARIAN CANCER USING ELECTRONIC MEDICAL RECORDS
    Clarke, Christina L.
    Kushi, Lawrence H.
    Chubak, Jessica
    Pawloski, Pamala A.
    Bulkley, Joanna E.
    Epstein, Mara M.
    Burnett-Hartman, Andrea N.
    Powell, Bethan
    Pearce, C. Leigh
    Feigelson, Heather Spencer
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 42 - 42
  • [8] Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer
    Yan Cai
    Tong Shu
    Hong Zheng
    BMC Women's Health, 24
  • [9] Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer
    Cai, Yan
    Shu, Tong
    Zheng, Hong
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [10] Characterization of primary-metastasis pairs in high-grade serous ovarian cancer with short- and long-term survival
    Kotnik, E. N.
    Spies, N.
    Miller, C. A.
    Li, T.
    Inkman, M.
    Zhang, J.
    Guo, L.
    Maher, C.
    McCourt, C. K.
    Thaker, P. H.
    Hagemann, A. R.
    Mutch, D. G.
    Powell, M. A.
    Fuh, K. C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 264 - 264